Subcutaneous liver tissue engineering is an attractive and minimally invasive approach used 2 for curative treat hepatic failure and inherited liver diseases. However, graft failure occurs 3 frequently due to insufficient infiltration of blood vessels (neoangiogenesis), while the 4 maintenance of hepatocyte phenotype and function requires in vivo development of the 5 complex cellular organization of the hepatic lobule. Here we describe a subcutaneous human 6 liver construction allowing for rapidly vascularized grafts by transplanting engineered cellular 7 sheets consisting of human primary hepatocytes adhered onto a fibroblast layer. The 8 engineered hepatocyte/fibroblast sheets (EHFSs) showed superior expression levels of 9 vascularization-associated growth factors (vascular endothelial growth factor, transforming 10 growth factor beta 1, and hepatocyte growth factor) in vitro. EHFSs developed into 11 vascularized subcutaneous human liver tissues (VSLTs) contained glycogen stores, 12 synthesized coagulation factor IX, and showed significantly higher synthesis rates of 13 liver-specific proteins (albumin and alpha 1 anti-trypsin) in vivo than tissues from 14 hepatocyte-only sheets. The present study describes a new approach for vascularized human 15 liver organogenesis under mouse skin. This approach could prove valuable for establishing 16 novel cell therapies for liver diseases.
anti-cytokeratin 18 (CK18) (ab668; 1:500), mouse anti-human vimentin (hVim) (ab8069; 1 1:500), rabbit anti-cluster of differentiation 31 (CD31) (ab28364; 1:50), rabbit anti-human 2 CD31 (hCD31) (ab76533; 1:250), rabbit anti-Ki67 (ab16667; 1:100) (all from Abcam, 3 Cambridge, MA), or rabbit anti-E-cadherin (E-cad) (sc-7870; 1:100) (Santa Cruz 4 Biotechnology, Santa Cruz, CA). Sections were then incubated for 1 h at room temperature in 5 an appropriate secondary antibody: horseradish peroxidase (HRP)-conjugated goat anti-rabbit 6 IgG (A0545; 1:300), biotin-conjugated goat anti-rabbit IgG (B8895; 1:800), fluorescein 7 isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (F9887; 1:320), FITC-conjugated 8 rabbit anti-mouse IgG (F9137; 1:200), tetramethylrhodamine isothiocyanate 9 (TRITC)-conjugated rabbit anti-mouse IgG (T2402; 1:400), FITC-conjugated ExtrAvidin 10 (E2761; 1:80), TRITC-conjugated ExtrAvidin (E3011; 1:150) (all from Sigma-Aldrich Japan, 11 Tokyo), or biotin-conjugated donkey anti-sheep IgG (ab97123; 1:500) (Abcam).
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HRP-conjugated secondary binding was visualized using the Dako liquid DAB+ substrate 13 chromogen system (Dako Japan). Nuclei stained with hematoxylin or
The exterior photographs of cell sheets were captured to evaluate the cell sheet sizes [27] .
23
The sizes of cell sheets were calculated as the ratio of the cell sheet area to the original TRCD culture surface area. To evaluate the thicknesses of the cell sheets, the HE stained 1 cross-sectional images of the cell sheets were captured. These areas and thickness were 2 measured using the NIS-Elements software program (Nikon, Tokyo). 
Human growth factors and liver-specific functions assay (ELISA) 15
Human platelet-derived growth factor BB (PDGF-BB), vascular endothelial growth factor 16 (VEGF), transforming growth factor beta 1 (TGF-β1), basic fibroblast growth factor (bFGF), 17 hepatocyte growth factor (HGF), and epidermal growth factor (EGF) in culture media Supporting Information S1. Evaluation of mRNA expression
S1.1. Total RNA extraction
Vascularized subcutaneous human liver tissues (VSLTs) in NOG mice at 7 and 14 days after EHFS transplantation, human liver tissues, and engineered hepatocyte/fibroblast sheets at 4 days after hepatocyte culture (EHFSs) were used for mRNA extraction using a spin column (NucleoSpin RNA II; Nippon Genetics Co. Ltd., Tokyo) according to the manufacturer's instructions.
S1.2. cDNA synthesis
cDNA was synthesized from 0.2 μg total RNA using a high-capacity cDNA reverse transcription kit (Applied Biosystems, Tokyo). The samples were then stored at −20 °C until they were processed for polymerase chain reaction (PCR) analysis.
S1.3. Real-time PCR
PCR was performed on an Applied Biosystems StepOnePlus Real-time PCR system using the TaqMan Gene Expression Assay Kit (Applied Biosystems; Supplementary Table 1 ). In brief, PCR amplification was performed using a reaction mixture containing 1 μL cDNA sample, 0.5 μL TaqMan Gene Expression Assay probe, 5 μL TaqMan Fast Universal PCR Master Mix solution (Applied Biosystems), and 13.5 μL nuclease-free water. Each amplification cycle consisted of 1 s at 95 °C and 20 s at 60 °C. The number of amplification cycles was 40 cycles.
S1.4. Data analysis of PCR
The comparative cycle time (ΔΔCT) method was used to quantify the gene expression levels according to the manufacturer's protocol. The expression levels of human VEGF, TGF-β1, and HGF were normalized to that of ACTB (EHFSs was set as 1.0) to establish the expression of angiogenic growth factors in vivo.
Data are presented as mean ± standard deviation and corresponded to 3 time points from one cell preparation.
